Solifenacin vs clonidine to reduce breast cancer hot flashes
Treatments studied
Part of Cancer, Skin clinical trials.
This trial compares two medicines—solifenacin and clonidine—to see which one better reduces hot flashes in people taking hormone-blocking cancer medicines. If you have frequent hot flashes, joining could help researchers find an effective option for symptom relief.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a past diagnosis of invasive breast cancer or DCIS
- You are currently taking tamoxifen or an aromatase inhibitor
- You are not taking hormone replacement therapy (for at least 1 month)
- You have hot flashes at least 14 times per week for at least 1 month
- If you take certain mood medicines (like venlafaxine or sertraline) or gabapentin, your dose must not have changed in the last 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new approach to reduce hot flashes in women taking hormone therapy for breast cancer. You may be able to join if you have at least 14 hot flashes a week and are not taking certain other treatments.
This study looks at whether acupuncture can lessen hot flashes caused by hormone therapy in people with hormone receptor–positive breast cancer. It may help if you still have frequent hot flashes while taking (or recently started) hormone treatment.
This study looks at whether acupuncture can reduce frequent, persistent hot flashes in people taking hormone therapy for hormone-receptor-positive breast cancer. It may help if your hot flashes are still happening despite ongoing treatment.
This trial tests whether acupuncture can reduce hot flashes in women with hormone receptor-positive breast cancer who are on hormone therapy. It aims to help manage this common side effect.
This trial tests whether a cooling mat can help reduce hot flushes and night sweats caused by hormone therapy for breast or prostate cancer. If you're bothered by these symptoms, you may be able to join.
This study tests whether a wearable cooling or heating device can help reduce hot flashes caused by hormone therapy for prostate cancer. You will use the device for 12 weeks and report how often and how much your hot flashes bother you.
Hear when a new Hot Flashes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.